Panacea Biotec · NSE: PANACEABIO · BSE: 531349
Q3 FY19 results · Oct–Dec 2018
Panacea Biotec reported revenue from operations of ₹113.85 crore and net loss of ₹23.02 crore for Q3 FY19 (Oct–Dec 2018), on a standalone basis.
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 113.85 | — | — | 118.58 | −4.0% |
| Other income | 4.12 | — | — | 3.30 | +24.8% |
| Total income | 117.97 | — | — | 121.88 | −3.2% |
| Profit before tax | (20.36) | — | — | (94.83) | Loss narrowed |
| Net profit for the period | (23.02) | — | — | (97.49) | Loss narrowed |
| EPS, basic (₹) | (3.76) | — | — | (15.92) | Loss narrowed |
| Net margin (%) | -20.2 | — | -82.2 |
Standalone
- Filed with BSE
- 16 Feb 2019, 14:28 IST
- Board meeting
- 14 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE